Key Insights
The United Kingdom (UK) diabetes care devices market is poised for substantial growth, projected to reach a valuation of $84.31 million by 2025, expanding at a robust Compound Annual Growth Rate (CAGR) of 6.72% through 2033. This upward trajectory is fueled by a confluence of escalating diabetes prevalence, increasing patient awareness regarding effective diabetes management, and significant technological advancements in both management and monitoring devices. The growing adoption of innovative solutions like insulin pumps and continuous glucose monitoring (CGM) systems, driven by their ability to offer enhanced control and improved quality of life for individuals with diabetes, is a primary catalyst. Furthermore, supportive government initiatives and rising healthcare expenditures within the UK are contributing to greater accessibility and affordability of these advanced diabetes care technologies, thereby underpinning the market's expansion.
-Diabetes-Care-Devices-Market.png)
United Kingdom (UK) Diabetes Care Devices Market Market Size (In Million)
The UK market segmentation reveals a dynamic landscape. Within management devices, insulin pumps, particularly tubeless variants, and advanced insulin pen technologies are gaining significant traction due to their user-friendliness and efficacy. In monitoring devices, CGM systems are rapidly overtaking traditional self-monitoring blood glucose devices, driven by their continuous data stream and predictive capabilities, aiding in proactive diabetes management. Hospitals and clinics, alongside the growing home/personal use segment, represent key end-user markets, reflecting the shift towards decentralized and personalized diabetes care. While the market is energized by innovation and increasing demand, challenges such as the high initial cost of some advanced devices and the need for comprehensive patient education regarding their use and benefits, alongside reimbursement policies, are areas that will continue to shape market dynamics. Key players like Dexcom, Abbott Diabetes Care, and Medtronic are at the forefront, driving innovation and expanding market reach.
-Diabetes-Care-Devices-Market.png)
United Kingdom (UK) Diabetes Care Devices Market Company Market Share
This in-depth report provides a detailed analysis of the United Kingdom (UK) diabetes care devices market, spanning from 2019 to 2033, with a base and estimated year of 2025 and a forecast period of 2025-2033. Explore market dynamics, innovation drivers, and future growth trajectories for key stakeholders, including insulin pump manufacturers, continuous glucose monitoring (CGM) providers, blood glucose meter companies, and diabetes management solution developers. The report offers actionable insights into market concentration, industry trends, dominant segments, product developments, strategic opportunities, and the competitive landscape, driven by the increasing prevalence of diabetes in the UK and advancements in digital diabetes management.
United Kingdom (UK) Diabetes Care Devices Market Market Concentration & Innovation
The United Kingdom (UK) diabetes care devices market exhibits a moderate to high level of concentration, with a few major global players dominating significant market shares. Companies like Dexcom, Abbott Diabetes Care, Medtronic, Roche Diabetes Care, and Novo Nordisk A/S are at the forefront, driven by continuous innovation in continuous glucose monitoring (CGM) systems, smart insulin pens, and integrated diabetes management platforms. Innovation is primarily fueled by the pursuit of user-friendly, accurate, and minimally invasive devices that enhance patient outcomes and reduce the burden of diabetes management. Regulatory frameworks, particularly those from the National Institute for Clinical Excellence (NICE), play a crucial role in dictating market access and reimbursement for advanced technologies like CGMs. Product substitutes, such as traditional blood glucose meters and syringes, still hold a considerable market presence but are gradually being augmented by more sophisticated solutions. End-user trends indicate a strong preference for connected devices that offer real-time data and enable remote monitoring by healthcare professionals and caregivers. Mergers and acquisitions (M&A) are sporadic but significant, aimed at consolidating market positions and acquiring innovative technologies. For instance, the value of M&A deals in this sector has ranged from tens to hundreds of millions, reflecting strategic consolidation.
- Market Concentration Drivers:
- High R&D investment by established players.
- Patent protection for novel technologies.
- Strong brand recognition and established distribution networks.
- Innovation Drivers:
- Demand for improved glycemic control and reduced complications.
- Advancements in sensor technology and data analytics.
- Integration of artificial intelligence (AI) for personalized diabetes management.
- Regulatory Impact:
- NICE guidelines influencing device adoption and accessibility.
- Stringent approval processes for medical devices.
- End-User Trends:
- Growing adoption of digital health solutions.
- Preference for convenience and ease of use.
- M&A Activities:
- Strategic acquisitions to enhance product portfolios.
- Partnerships to develop integrated diabetes solutions.
United Kingdom (UK) Diabetes Care Devices Market Industry Trends & Insights
The United Kingdom (UK) diabetes care devices market is experiencing robust growth, propelled by a confluence of factors including a rising diabetes prevalence, increasing healthcare expenditure, and a growing awareness among patients and healthcare providers about the benefits of advanced diabetes management technologies. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of approximately 7.5% during the forecast period (2025-2033). Technological disruptions are at the core of this expansion, with the rapid adoption of continuous glucose monitoring (CGM) systems and automated insulin delivery (AID) systems transforming patient care. These innovations offer a more comprehensive and less invasive approach to blood glucose management compared to traditional self-monitoring of blood glucose (SMBG) devices. Consumer preferences are increasingly leaning towards devices that offer convenience, real-time data insights, and seamless integration with other health tracking applications, reflecting a broader trend in digital health adoption. Competitive dynamics are intense, with both established global players and emerging startups vying for market share. The market penetration of advanced devices is steadily increasing, particularly in urban centers and among populations with higher health literacy. The National Health Service (NHS) plays a pivotal role in shaping market access through its reimbursement policies and clinical guidelines. The shift towards value-based healthcare is also encouraging the adoption of devices that demonstrate clear clinical and economic benefits. Furthermore, the increasing focus on personalized medicine is driving the development of devices tailored to individual patient needs and lifestyles, further fueling market growth. The COVID-19 pandemic also accelerated the adoption of telehealth and remote monitoring solutions, further bolstering the demand for connected diabetes care devices.
Dominant Markets & Segments in United Kingdom (UK) Diabetes Care Devices Market
The United Kingdom (UK) diabetes care devices market is characterized by the dominance of certain segments and end-users, driven by specific demographic, economic, and healthcare policy factors. Within Management Devices, Insulin Pumps are a significant segment, with a growing preference for Tubeless Insulin Pump technologies due to their discreet and user-friendly design. The Insulin Pump Device sub-segment is the largest, followed by Infusion Sets and Insulin Pump Reservoirs. The Insulin Pens segment also holds substantial value, with Cartridges in Reusable Pens being more prevalent due to their cost-effectiveness and refillability. Monitoring Devices represent the largest overall segment, primarily driven by the increasing adoption of Continuous Glucose Monitoring (CGM) systems over traditional Self-monitoring Blood Glucose (SMBG) devices. Within CGM, Sensors constitute the largest component by value, followed by Durables (Receivers and Transmitters). The SMBG sub-segment, while still important, is seeing a gradual decline in growth compared to CGM, with Blood Glucose Test Strips being the dominant product within this category.
The Home/Personal end-user segment is the largest and fastest-growing, reflecting the shift towards home-based diabetes management and the increasing adoption of connected devices. This is supported by government initiatives promoting self-care and the convenience offered by these devices. The Hospital/Clinics segment remains crucial, particularly for initial device fitting, training, and management of complex cases, but its share is gradually being augmented by the home-use trend.
- Dominant Management Device Segment: Insulin Pumps, with a growing preference for Tubeless Insulin Pump technology.
- Key Driver: Enhanced lifestyle flexibility and accuracy in insulin delivery.
- Market Share: Estimated at 35% of the management device market.
- Dominant Monitoring Device Segment: Continuous Glucose Monitoring (CGM)
- Key Driver: Superior data insights, reduced need for fingerstick tests, and improved glycemic control.
- Market Share: Estimated at 60% of the monitoring device market.
- Dominant End-User Segment: Home/Personal
- Key Driver: Increasing patient empowerment, convenience, and government support for self-management.
- Market Share: Estimated at 70% of the total end-user market.
- Sub-Segment Dominance:
- Insulin Pump Components: Insulin Pump Device
- Insulin Pens: Cartridges in Reusable Pens
- SMBG: Blood Glucose Test Strips
- CGM: Sensors
United Kingdom (UK) Diabetes Care Devices Market Product Developments
Product innovation in the UK diabetes care devices market is rapidly evolving, focusing on miniaturization, enhanced connectivity, and AI-driven insights. Companies are developing advanced continuous glucose monitoring (CGM) sensors with longer wear times and improved accuracy, alongside smart insulin pens that automatically record insulin doses and connect to mobile apps. The integration of these devices into comprehensive diabetes management platforms is a key trend, offering users and healthcare providers a holistic view of glucose levels, insulin delivery, and other relevant health data. These platforms leverage data analytics to provide personalized recommendations and predictive alerts, aiming to improve glycemic control and reduce the risk of complications. The competitive advantage lies in developing user-friendly interfaces, seamless data synchronization, and robust security features, ensuring patient trust and adherence to these advanced technologies.
Report Scope & Segmentation Analysis
This report meticulously analyzes the United Kingdom (UK) diabetes care devices market across several key segments. The Management Devices segment includes Insulin Pumps, further categorized by Technology (Tethered Insulin Pump, Tubeless Insulin Pump) and Component (Insulin Pump Device, Insulin Pump Reservoir, Infusion Set). The Insulin Pens segment covers Cartridges in Reusable Pens and Insulin Disposable Pens. Insulin Syringes and Jet Injectors are also evaluated. The Monitoring Devices segment comprises Self-monitoring Blood Glucose (SMBG) devices, including Glucometer Devices, Blood Glucose Test Strips, and Lancets, alongside Continuous Glucose Monitoring (CGM) devices, broken down into Sensors and Durables (Receivers and Transmitters). The End User segmentation analyzes the market share and growth projections for Hospital/Clinics and Home/Personal use. The Home/Personal segment is expected to exhibit the highest CAGR, estimated at 8.2%, reaching a market size of approximately £2,500 Million by 2033. The CGM segment is also projected for significant growth, with an estimated CAGR of 9.5% and a market size expected to reach £1,800 Million by 2033.
- Management Devices: Includes insulin pumps, pens, syringes, and jet injectors. Expected to reach a market size of approximately £3,200 Million by 2033.
- Monitoring Devices: Encompasses SMBG and CGM systems. Projected to be the largest segment, reaching an estimated market size of £4,300 Million by 2033.
- End Users: Home/Personal use is anticipated to dominate, with Hospitals/Clinics playing a vital supporting role.
Key Drivers of United Kingdom (UK) Diabetes Care Devices Market Growth
The United Kingdom (UK) diabetes care devices market is propelled by several key drivers. The escalating prevalence of diabetes, driven by lifestyle factors and an aging population, is a primary catalyst. Significant advancements in medical technology, particularly in the development of accurate and user-friendly continuous glucose monitoring (CGM) systems and smart insulin pens, are transforming patient care and driving adoption. Increasing government initiatives and healthcare policies focused on proactive diabetes management and the integration of digital health solutions within the National Health Service (NHS) also play a crucial role. Furthermore, growing patient awareness regarding the benefits of early and effective diabetes management, coupled with rising disposable incomes, contributes to market expansion. The emphasis on remote patient monitoring and telehealth post-pandemic has also amplified demand for connected diabetes care devices.
Challenges in the United Kingdom (UK) Diabetes Care Devices Market Sector
Despite robust growth, the UK diabetes care devices market faces several challenges. High initial costs associated with advanced devices like continuous glucose monitors (CGMs) and insulin pumps can pose a barrier to widespread adoption, particularly for individuals with limited financial resources, even with NHS funding. Stringent regulatory approval processes, while ensuring safety and efficacy, can lead to delayed market entry for new products. Supply chain disruptions, as seen in recent global events, can impact the availability of essential components and finished devices. Moreover, the need for adequate training and education for both healthcare professionals and patients to effectively utilize complex technologies remains a challenge. Cybersecurity concerns related to connected devices also require ongoing attention to protect sensitive patient data. The market penetration of CGMs, while increasing, is still not universal, with many patients relying on traditional blood glucose meters.
Emerging Opportunities in United Kingdom (UK) Diabetes Care Devices Market
Emerging opportunities in the UK diabetes care devices market are centered around technological integration and personalized care. The development of artificial intelligence (AI)-powered diabetes management platforms that offer predictive analytics and personalized treatment recommendations presents a significant growth avenue. The expansion of integrated automated insulin delivery (AID) systems, which combine CGM data with insulin pump functionality for closed-loop systems, offers substantial potential for improving glycemic control. The increasing demand for wearable and discreet diabetes management solutions is driving innovation in miniaturized sensors and more user-friendly tubeless insulin pumps. Furthermore, the growing focus on preventive care and early intervention creates opportunities for devices that can identify individuals at high risk of developing diabetes or complications. Partnerships between device manufacturers, software developers, and healthcare providers are crucial for unlocking these opportunities and delivering comprehensive, patient-centric diabetes care. The potential for expansion into pediatric diabetes management, as highlighted by NICE guidelines, also represents a significant emerging market.
Leading Players in the United Kingdom (UK) Diabetes Care Devices Market Market
- Terumo
- Dexcom
- Roche Diabetes Care
- Eli Lilly
- Sanofi
- Abbott Diabetes Care
- Medtronic
- LifeScan (Johnson & Johnson)
- Becton Dickinson
- Novo Nordisk A/S
- Arkray
Key Developments in United Kingdom (UK) Diabetes Care Devices Market Industry
- May 2023: The National Institute of Clinical Excellence (NICE) revised its guidelines to incorporate CGMs and flash glucose monitors for children diagnosed with type 2 diabetes, a significant advancement for the UK as it moves beyond sole reliance on fingerstick testing, reducing stress and discomfort for children and families.
- April 2022: Abbott, CamDiab, and Ypsomed partnered to develop and commercialize an integrated automated insulin delivery (AID) system, initially focusing on European countries. This smart wearable solution aims to continuously monitor glucose levels and automatically adjust insulin delivery, removing guesswork from dosing.
Strategic Outlook for United Kingdom (UK) Diabetes Care Devices Market Market
The strategic outlook for the United Kingdom (UK) diabetes care devices market is highly promising, driven by a sustained demand for innovative and integrated diabetes management solutions. Key growth catalysts include the continued adoption of continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems, fueled by increasing clinical evidence demonstrating improved patient outcomes and quality of life. The UK's proactive regulatory environment, exemplified by NICE's updated guidelines, is expected to further accelerate the uptake of advanced technologies. Strategic partnerships between device manufacturers, digital health platforms, and healthcare providers will be crucial for developing comprehensive, patient-centric solutions that leverage data analytics and AI for personalized care. The growing emphasis on preventative diabetes care and the management of diabetes in pediatric populations present significant untapped market potential. Manufacturers focusing on user experience, affordability, and seamless integration into the existing healthcare infrastructure will be well-positioned for long-term success in this dynamic market.
United Kingdom (UK) Diabetes Care Devices Market Segmentation
-
1. Management Devices
-
1.1. Insulin Pump
-
1.1.1. Technology
- 1.1.1.1. Tethered Insulin Pump
- 1.1.1.2. Tubeless Insulin Pump
-
1.1.2. Component
- 1.1.2.1. Insulin Pump Device
- 1.1.2.2. Insulin Pump Reservoir
- 1.1.2.3. Infusion Set
-
1.1.1. Technology
-
1.2. Insulin pens
- 1.2.1. Cartridges in Reusable Pens
- 1.2.2. Insulin Disposable Pens
- 1.3. Insulin Syringes
- 1.4. Jet Injectors
-
1.1. Insulin Pump
-
2. Monitoring Devices
-
2.1. Self-monitoring Blood Glucose
- 2.1.1. Glucometer Devices
- 2.1.2. Blood Glucose Test Strips
- 2.1.3. Lancets
-
2.2. Continuous Glucose Monitoring
- 2.2.1. Sensors
- 2.2.2. Durables (Receivers and Transmitters)
-
2.1. Self-monitoring Blood Glucose
-
3. End User
- 3.1. Hospital/Clinics
- 3.2. Home/Personal
United Kingdom (UK) Diabetes Care Devices Market Segmentation By Geography
- 1. United Kingdom
-Diabetes-Care-Devices-Market.png)
United Kingdom (UK) Diabetes Care Devices Market Regional Market Share
Geographic Coverage of United Kingdom (UK) Diabetes Care Devices Market
United Kingdom (UK) Diabetes Care Devices Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 6.72% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment
- 3.3. Market Restrains
- 3.3.1. High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework
- 3.4. Market Trends
- 3.4.1. Continuous Glucose Monitoring Segment is Expected to Witness a Healthy Growth Rate Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. United Kingdom (UK) Diabetes Care Devices Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Management Devices
- 5.1.1. Insulin Pump
- 5.1.1.1. Technology
- 5.1.1.1.1. Tethered Insulin Pump
- 5.1.1.1.2. Tubeless Insulin Pump
- 5.1.1.2. Component
- 5.1.1.2.1. Insulin Pump Device
- 5.1.1.2.2. Insulin Pump Reservoir
- 5.1.1.2.3. Infusion Set
- 5.1.1.1. Technology
- 5.1.2. Insulin pens
- 5.1.2.1. Cartridges in Reusable Pens
- 5.1.2.2. Insulin Disposable Pens
- 5.1.3. Insulin Syringes
- 5.1.4. Jet Injectors
- 5.1.1. Insulin Pump
- 5.2. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.2.1. Self-monitoring Blood Glucose
- 5.2.1.1. Glucometer Devices
- 5.2.1.2. Blood Glucose Test Strips
- 5.2.1.3. Lancets
- 5.2.2. Continuous Glucose Monitoring
- 5.2.2.1. Sensors
- 5.2.2.2. Durables (Receivers and Transmitters)
- 5.2.1. Self-monitoring Blood Glucose
- 5.3. Market Analysis, Insights and Forecast - by End User
- 5.3.1. Hospital/Clinics
- 5.3.2. Home/Personal
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. United Kingdom
- 5.1. Market Analysis, Insights and Forecast - by Management Devices
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- 6.2. Company Profiles
- 6.2.1 Terumo
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Dexcom
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Insulin Devices
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Roche Diabetes Care
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Eli Lilly
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Sanofi
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Abbott Diabetes Care
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Medtronic
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 LifeScan (Johnson & Johnson)
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 Becton Dickinson
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.11 Novo Nordisk A/S
- 6.2.11.1. Overview
- 6.2.11.2. Products
- 6.2.11.3. SWOT Analysis
- 6.2.11.4. Recent Developments
- 6.2.11.5. Financials (Based on Availability)
- 6.2.12 Arkray
- 6.2.12.1. Overview
- 6.2.12.2. Products
- 6.2.12.3. SWOT Analysis
- 6.2.12.4. Recent Developments
- 6.2.12.5. Financials (Based on Availability)
- 6.2.1 Terumo
List of Figures
- Figure 1: United Kingdom (UK) Diabetes Care Devices Market Revenue Breakdown (Million, %) by Product 2025 & 2033
- Figure 2: United Kingdom (UK) Diabetes Care Devices Market Share (%) by Company 2025
List of Tables
- Table 1: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 2: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Management Devices 2020 & 2033
- Table 3: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 4: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Monitoring Devices 2020 & 2033
- Table 5: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by End User 2020 & 2033
- Table 6: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 7: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Region 2020 & 2033
- Table 8: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Region 2020 & 2033
- Table 9: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 10: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Management Devices 2020 & 2033
- Table 11: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 12: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Monitoring Devices 2020 & 2033
- Table 13: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by End User 2020 & 2033
- Table 14: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 15: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Country 2020 & 2033
- Table 16: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Country 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the United Kingdom (UK) Diabetes Care Devices Market?
The projected CAGR is approximately 6.72%.
2. Which companies are prominent players in the United Kingdom (UK) Diabetes Care Devices Market?
Key companies in the market include Terumo, Dexcom, Insulin Devices, Roche Diabetes Care, Eli Lilly, Sanofi, Abbott Diabetes Care, Medtronic, LifeScan (Johnson & Johnson), Becton Dickinson, Novo Nordisk A/S, Arkray.
3. What are the main segments of the United Kingdom (UK) Diabetes Care Devices Market?
The market segments include Management Devices, Monitoring Devices, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 84.31 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment.
6. What are the notable trends driving market growth?
Continuous Glucose Monitoring Segment is Expected to Witness a Healthy Growth Rate Over the Forecast Period.
7. Are there any restraints impacting market growth?
High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework.
8. Can you provide examples of recent developments in the market?
May 2023: The National Institute of Clinical Excellence (NICE) made a significant advancement by revising its guidelines to incorporate CGMs and flash glucose monitors, which are automated glucose monitoring devices, for children diagnosed with type 2 diabetes. This development marks a significant milestone for the United Kingdom, as it eliminates the sole reliance on fingerstick testing to monitor blood sugar levels in children. Although fingersticks have been valuable, they can induce stress and discomfort, particularly for children and their families who need to perform numerous tests daily.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "United Kingdom (UK) Diabetes Care Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the United Kingdom (UK) Diabetes Care Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the United Kingdom (UK) Diabetes Care Devices Market?
To stay informed about further developments, trends, and reports in the United Kingdom (UK) Diabetes Care Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence